Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Chapple

Showing results (161-170 of 271) with videos related to

Pageof 28
Sort By:
Expert Opinion on Pharmacotherapy|August 29, 2012
Silodosin : a new subtype selective alpha-1 antagonist for the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasiaNadir I Osman, Christopher R Chapple, Francisco Cruz, et al.
European Urology|July 5, 2008
The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysisChristopher R Chapple, Vik Khullar, Zahava Gabriel, et al.
European Urology|October 11, 2014
Effect of tadalafil on male lower urinary tract symptoms: an integrated analysis of storage and voiding international prostate symptom subscores from four randomised controlled trialsChristopher R Chapple, Claus G Roehrborn, Kevin McVary, et al.
Nature Reviews. Urology|May 1, 2024
Strengthening preclinical testing to increase safety in surgical meshNicholas T H Farr, Victoria L Workman, Christopher R Chapple, et al.
Neurourology and Urodynamics|December 21, 2012
What was hot at the ICS meeting 2012Altaf Mangera, Rufus Cartwright, Kari A O Tikkinen, et al.
BJU International|May 26, 2010
Efficacy and safety of tolterodine extended-release in men with overactive bladder symptoms treated with an α-blocker: effect of baseline prostate-specific antigen concentrationChristopher R Chapple, Sender Herschorn, Paul Abrams, et al.
BJU International|February 17, 2015
A review of detrusor overactivity and the overactive bladder after radical prostate cancer treatmentNikesh Thiruchelvam, Francesco Cruz, Mike Kirby, et al.
European Urology|June 22, 2005
An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinenceChristopher R Chapple, François Haab, Mauro Cervigni, et al.
BJU International|May 23, 2012
Mesh social networking: a patient-driven processNadir I Osman, Altaf Mangera, Sabiniano Roman, et al.
European Urology|April 28, 2015
Flexible cystourethroscopy in the follow-up of posturethroplasty patients and characterisation of recurrencesSatish K Goonesinghe, Christopher J Hillary, Timothy R Nicholson, et al.
Pageof 28

Showing results (161-170 of 271) with videos related to

Sort By:
Pageof 28
Expert Opinion on Pharmacotherapy|August 29, 2012
Silodosin : a new subtype selective alpha-1 antagonist for the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasiaNadir I Osman, Christopher R Chapple, Francisco Cruz, et al.
European Urology|July 5, 2008
The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysisChristopher R Chapple, Vik Khullar, Zahava Gabriel, et al.
European Urology|October 11, 2014
Effect of tadalafil on male lower urinary tract symptoms: an integrated analysis of storage and voiding international prostate symptom subscores from four randomised controlled trialsChristopher R Chapple, Claus G Roehrborn, Kevin McVary, et al.
Nature Reviews. Urology|May 1, 2024
Strengthening preclinical testing to increase safety in surgical meshNicholas T H Farr, Victoria L Workman, Christopher R Chapple, et al.
Neurourology and Urodynamics|December 21, 2012
What was hot at the ICS meeting 2012Altaf Mangera, Rufus Cartwright, Kari A O Tikkinen, et al.
BJU International|May 26, 2010
Efficacy and safety of tolterodine extended-release in men with overactive bladder symptoms treated with an α-blocker: effect of baseline prostate-specific antigen concentrationChristopher R Chapple, Sender Herschorn, Paul Abrams, et al.
BJU International|February 17, 2015
A review of detrusor overactivity and the overactive bladder after radical prostate cancer treatmentNikesh Thiruchelvam, Francesco Cruz, Mike Kirby, et al.
European Urology|June 22, 2005
An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinenceChristopher R Chapple, François Haab, Mauro Cervigni, et al.
BJU International|May 23, 2012
Mesh social networking: a patient-driven processNadir I Osman, Altaf Mangera, Sabiniano Roman, et al.
European Urology|April 28, 2015
Flexible cystourethroscopy in the follow-up of posturethroplasty patients and characterisation of recurrencesSatish K Goonesinghe, Christopher J Hillary, Timothy R Nicholson, et al.
Pageof 28